Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RECOVER-VITAL: A Platform Protocol for Evaluation of Interventions for Viral Persistence, Viral Reactivation, and Immune Dysregulation in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

NCT05595369 is registered in ClinicalTrials.gov with Kanecia Obie Zimmerman as lead sponsor.

NCT NCT05595369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05595369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RECOVER-VITAL: A Platform Protocol for Evaluation of Interventions for Viral Persistence, Viral Reactivation, and Immune Dysregulation in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Lead sponsor
Kanecia Obie Zimmerman
Phase
Phase 2
Overall status
Completed
Start date
July 26, 2023
Completion date
March 13, 2025
Enrollment
963 (actual)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

long covid, long covid19